Joseph Stapleton, MD
Pain Medicine · Portland, ORNPI 1700812898
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 70.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $9,781, more than ten times the $328 reported in 2019.
Across 93 payments — averaging $141.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Nevro Corp.$2K
- Curonix LLC$369
- Vertos Medical, Inc.$314
- Globus Medical$206
- Stryker$200
- plus $510 from 7 others
What the payments were for
- Consulting fees$3703%
- Speaking & faculty fees$6,53150%
- Travel & lodging$2,25517%
- Food & beverage$3,97430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 20 | $9,242 |
| Nevro Corp. | 32 | $2,290 |
| Curonix LLC | 7 | $369 |
| Vertos Medical, Inc. | 6 | $314 |
| Globus Medical | 12 | $206 |
| Stryker | 4 | $200 |
| Boston Scientific | 1 | $131 |
| Biotronik NRO, Inc. | 1 | $104 |
| Si-bone, Inc. | 1 | $86 |
| SPR Therapeutics, Inc | 3 | $70 |
| Nalu Medical, Inc. | 3 | $62 |
| Medtronic(2 entities) | 2 | $36 |
| Zimmer Biomet | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,131 in reported general payments places this provider in the 80th percentile of 57 pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 43 | $548 |
| Gabapentin | 36 | $317 |
| Tramadol Hcl | 12 | $83 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Portland
- Kimberly MauerPortland$59K
- Stuart RosenblumPortland$31K
- Andrew OhPortland$30K
- Salman HiraniPortland$5K
- Behnum HabibiPortland$3K
- Sandy ChristiansenPortland$3K
- Ginevra LiptanPortland$2K
- James BertolaPortland$2K
- Robert FoegePortland$2K
- Irvan BubicPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.